Park Ha Biological Technology reported total assets of $7.46M and total liabilities of $2.07M for the quarter ended Apr 2026, up 229.4% year over year. This balance sheet covers 5 quarters of results from Oct 2023 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Oct2023 | Oct2024 | Apr2025 | Oct2025 | Apr2026 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 1.03M | 0.55M | 1.35M | 3.79M | 0.63M |
| Short-term InvestmentsInvestments (Current) | 598.00 | 0.02M | 0.00M | 0.01M | 5.03M |
| Cash & Current Investments | 1.03M | 0.57M | 1.35M | 3.80M | 5.66M |
| Receivables - NetNet Receivables | 0.36M | 0.75M | 1.00M | 0.26M | -3.52M |
| Receivables - OtherOther Receivables | -0.27M | 0.07M | 0.05M | 35.00 | 769.00 |
| Receivables | 0.10M | 0.82M | 1.05M | 0.26M | -3.52M |
| Raw Materials | 0.04M | 0.02M | 0.02M | 0.01M | 0.03M |
| Finished Goods | 0.06M | 0.05M | 0.05M | 0.07M | 0.09M |
| Inventory | 0.10M | 0.07M | 0.07M | 0.08M | 0.10M |
| Current Assets | 2.18M | 2.84M | 5.58M | 5.50M | 6.78M |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.04M | 0.10M | 0.09M | 0.16M | 0.30M |
| Long-Term Investments | 1.01M | 1.88M | 2.22M | 3.72M | 3.48M |
| Intangibles | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Goodwill & Intangibles | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Long-Term Deferred Tax | 0.06M | 0.06M | 0.06M | 0.08M | 0.16M |
| Other Non-Current Assets | 0.06M | 0.06M | 0.06M | 0.11M | 0.19M |
| Non-Current Assets | 0.09M | 0.24M | 0.25M | 0.45M | 0.68M |
| Assets | 2.26M | 3.08M | 5.83M | 5.95M | 7.46M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 0.20M | 0.02M | 0.02M | 0.01M | 0.01M |
| Notes Payables | 0.01M | 0.05M | 0.06M | 0.08M | 0.06M |
| Payables | 0.21M | 0.08M | 0.08M | 0.09M | 0.07M |
| Accumulated Expenses | 0.13M | 0.16M | 0.15M | 0.19M | 0.17M |
| Other Accumulated Expenses | 0.07M | 0.01M | 0.01M | 0.17M | |
| Short term Debt | 1.46M | -3.19M | -3.48M | ||
| Current Leases | 0.02M | 0.02M | 0.03M | 0.10M | 0.13M |
| Current Taxes | 0.58M | 1.00M | 1.20M | 1.38M | 1.51M |
| Current Deferred Revenue | 0.25M | 0.33M | 0.12M | 0.19M | 0.19M |
| Total Current Liabilities | 1.24M | 1.52M | 1.52M | 1.88M | 2.02M |
| Non-Current Liabilities | |||||
| Operating Leases | 0.01M | 0.05M | 0.06M | 0.08M | 0.06M |
| Other Non-Current Liabilities | 0.03M | 0.13M | 0.13M | 0.22M | 0.22M |
| Total Non-Current Liabilities | 0.01M | 0.05M | 0.06M | 0.08M | 0.06M |
| Total Liabilities | 1.25M | 1.58M | 1.58M | 1.96M | 2.07M |
| Shareholder's Equity | |||||
| Total Debt | 0.01M | 1.51M | 0.06M | -3.11M | -3.42M |
| Common Equity | 1.01M | 1.51M | 4.25M | 3.99M | 5.39M |
| Liabilities and Shareholders Equity | 2.26M | 3.08M | 5.83M | 5.95M | 7.46M |
| Retained Earnings | 1.16M | 0.27M | -19.56M | -24.18M | -25.10M |
| Preferred Shares | 119.00 | 296.00 | 0.00M |